Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2003
10/02/2003WO2003079969A2 Compositions and methods for treating and preventing necrosis
10/02/2003WO2003079885A2 Inhalable sustained therapeutic formulations
10/02/2003WO2003079750A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
10/02/2003WO2003042173A8 Nk1 antagonists
10/02/2003WO2003035694A3 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
10/02/2003WO2003018031A3 Single dose azithromycin for treating respiratory infections
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002074323A3 Using neural thread proteins to treat tumors and other hyperproliferative disorders
10/02/2003WO2002069944A3 Novel medicament compositions based on anticholinergics and on nk1 receptor antagonists
10/02/2003WO2002026781A3 Ige receptor antagonists
10/02/2003WO2002022573A3 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
10/02/2003WO2002000656A3 Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives
10/02/2003WO2001098508A3 Transgenic mice containing targeted gene disruptions
10/02/2003US20030187276 Hydrophobic polyamine analogs and methods for their use
10/02/2003US20030187260 Thienopyrimidines
10/02/2003US20030187257 Phosphodiesterase inhibitor; antiinflammatory agnets, autoimmune disease; antihistamine agents; skin disorders
10/02/2003US20030187255 Therapeutic heterocycles
10/02/2003US20030187052 Controrlling concentration of tumor necrosis factor, phosphodiesterase inhibitor; controlling cell differentiation, proliferation; antiinflammatory agents; cardiovascular disorders
10/02/2003US20030187040 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
10/02/2003US20030187031 Antiinflammatory agents; autoimmune disease; rheumatic disorders
10/02/2003US20030187020 Chemical compounds
10/02/2003US20030187009 Analgesics, diarrhea, anticonvulsants, antitussive agents or drug abuse therapy
10/02/2003US20030187007 Inhibitors of protein kinase for the treatment of disease
10/02/2003US20030187004 Central nervous system disorders; Alzheimer's disease
10/02/2003US20030186989 Antihistamines; respiratory system disorders
10/02/2003US20030186988 Lymphocyte disease; autoimmune disease
10/02/2003US20030186982 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
10/02/2003US20030186981 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases
10/02/2003US20030186974 Pyrrolyl- and imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
10/02/2003US20030186966 Antiinflammatory agents; autoimmune disease; antiallergens
10/02/2003US20030186964 Piperdines for use as orexin receptor antagonists
10/02/2003US20030186960 Nervous system regeneration
10/02/2003US20030186958 Viricides, vision defects, oral diseases, antiarthritic agents, multiple sclerosis, anticancer agents
10/02/2003US20030186945 Method of preparing and use of prodrugs of betulinic acid derivatives
10/02/2003US20030186941 Cyclopenteneone derivatives
10/02/2003US20030186894 Dry powder compositions having improved dispersivity
10/02/2003US20030186889 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/02/2003US20030186875 Uses of mammalian cytokine; related reagents
10/02/2003US20030186855 Systemically administering cyclic peptide compound, salt, ester or prodrug for reducing toxicity associated with the administration of cyclosporin A
10/02/2003US20030186842 Contacting a cell population with an inhibiting effective amount of a reagent that suppresses the protease activity of at least one member of the interleukin-1beta- converting enzyme (ICE)/CED-3 family
10/02/2003US20030186325 Method of screening for inhibitors of osteopontin
10/02/2003US20030186308 Prostacyclin-stimulating factor-2
10/02/2003US20030185912 Anti-microbial compositions and methods of using same
10/02/2003US20030185819 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation.
10/02/2003US20030185818 Humanized antibody against cd18
10/02/2003US20030185816 Modified immunogenic self-protein and a surfactant capable of acting as a solubiliser, especially modified human TNF alpha and cetylpyridinium chloride
10/02/2003US20030185815 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/02/2003US20030185791 TNF-derived peptides for use in treating oedema
10/02/2003US20030185765 Composition for pulmonary administration comprising a drug and a hydrophobic amino acid
10/02/2003CA2756798A1 (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
10/02/2003CA2480385A1 Alkoxypyridine derivatives as nitric oxide synthase inhibitors
10/02/2003CA2480302A1 Compositions and methods for treating and preventing necrosis
10/02/2003CA2480039A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient
10/02/2003CA2480032A1 Use of ltb4 antagonists in veterinary medicine
10/02/2003CA2479686A1 A composition for treating pollinosis comprising an extract of sasa albo-marginata
10/02/2003CA2479279A1 Fused bicyclic pyridine derivative as tachykinin receptor antagonist
10/02/2003CA2479277A1 Fused bicyclic pyrimidine derivatives
10/02/2003CA2479256A1 Phosphate prodrugs of fluorooxindoles
10/02/2003CA2479150A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
10/02/2003CA2478974A1 Inhalable sustained therapeutic formulations
10/02/2003CA2477651A1 Kinase inhibitors
10/02/2003CA2475529A1 Methods for treating chronic obstructive pulmonary disease (copd)
10/01/2003EP1348714A1 Polypeptide useful as anti-allergic/antiasthmatic, methods for the preparation thereof and pharmaceutical compositions containing such polypeptide and their use
10/01/2003EP1348709A2 Thiazolo (4,5-D) pyrimidine compounds
10/01/2003EP1348707A1 Pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
10/01/2003EP1348701A1 (2,4-disubstituted-thiazol-5-yl) amine compounds as PDE7 inhibitors
10/01/2003EP1348433A1 Thiazol-2-yl-imine compounds as PDE-7 inhibitors
10/01/2003EP1347990A2 Peptide mit inhibierender aktivität zur produktion von stickstoffmonoxid
10/01/2003EP1347981A1 Condensed purine derivatives as a 1? adenosine receptor antagonists
10/01/2003EP1347980A1 Compounds specific to adenosine-a1,-a2a, and- a3-receptor and uses thereof
10/01/2003EP1347979A1 Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands
10/01/2003EP1347976A2 Tricyclic purine compounds and their analogs as inhibiotrs of cytokine signalling
10/01/2003EP1347974A1 Aminotriazolopyridiine derivatives as adenosine receptor ligands
10/01/2003EP1347971A1 Thiazolyl inhibitors of tec family tyrosine kinases
10/01/2003EP1347968A1 Lfa-1 antagonist compounds
10/01/2003EP1347966A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/01/2003EP1347959A1 Indole derivatives as ligands of thyroid receptors
10/01/2003EP1347780A1 Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides
10/01/2003EP1347762A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)
10/01/2003EP1347761A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
10/01/2003EP1347748A2 Hydrostatic delivery system for controlled delivery of agent
10/01/2003EP1202954B1 Novel aminobenzophenones
10/01/2003EP1200435B1 Purine derivatives inhibitors of tyrosine protein kinase syk
10/01/2003EP0996621B1 TRIAZOLO[4,5-d]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS
10/01/2003EP0810854B1 Aerosols containing beclomethazone nanoparticle dispersions
10/01/2003EP0772596B1 INDOLIZINE sPLA2 INHIBITORS
10/01/2003EP0662087B1 Method for purifying retinal pigmented epithelium derived neurotrophic factor
10/01/2003CN1446218A Benzimidazole derivatives, preparation method and therapeutic use thereof
10/01/2003CN1446217A Beta-carboline derivatives useful as inhibitors of phosphodiesterase
10/01/2003CN1446202A 2-aminopyridine compounds and use thereof as drugs
10/01/2003CN1446111A Microencapsulated fragrances and methods of coating microcapsules
10/01/2003CN1446101A Combination product comprising melagatran and factor VLLa inhibitor
10/01/2003CN1446098A Modulation of alpha-6 integrin-mediated responses
10/01/2003CN1446083A Coated medicament forms with controlled active substance rdease
10/01/2003CN1445225A Intermediate for preparing benzothiophene amide derivate
10/01/2003CN1444980A Medicine for treating acute external affection heat disease and its preparing method
10/01/2003CN1444970A Soft capsule of forsythia fruit oil
10/01/2003CN1444961A Medicine for curing acute plaryngitis, acute laryngitis and acute tonsillitis as well as its preparing method
10/01/2003CN1444945A Medicine containing fritillary total alkali for treating disease of respiratory system and its preparing method
10/01/2003CN1444937A Drop pills of andrographolide and its preparing method
1 ... 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 ... 878